Results 171 to 180 of about 3,483,015 (354)
Rebuilding an Immune-Mediated Central Nervous System Disease: Weighing the Pathogenicity of Antigen-Specific versus Bystander T Cells [PDF]
Dorian B. McGavern, Phi Truong
openalex +1 more source
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit+19 more
wiley +1 more source
Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment [PDF]
Michael I. Luster+5 more
openalex +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
Immune system and cardiovascular disease [PDF]
openaire +3 more sources
Johann Lechner,1 Jürgen Aschoff,2 Tatjana Rudi3 1Clinic for Integrative Dentistry, Munich, Germany; 2Center for Integrative Healing, Wuppertal, Germany; 3Statistics at Institute for Epidemiological Studies, Berlin, Germany Background: Recent ...
Lechner J, Aschoff J, Rudi T
doaj
Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? [PDF]
Alan Chait+3 more
openalex +1 more source
Interplay of integrins and selectins in metastasis
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva+2 more
wiley +1 more source
Clinical analysis of anti⁃leucine⁃rich glioma⁃inactivated 1 antibody⁃related encephalitis
Objective To explore the clinical characteristics of anti⁃leucine⁃rich glioma⁃inactivated 1 (LGI1) antibody⁃related encephalitis. Methods and Results Clinical data of 6 patients with anti⁃LGI1 antibody⁃related encephalitis from September 2016 to April ...
Qing⁃qing ZHAO+4 more
doaj